Log in to save activitiesYour saved activities will show here so that you can easily access them whenever you're ready. Log in hereCME & EducationLog in to keep track of your credits.
Please confirm that you would like to log out of Medscape.
If you log out, you will be required to enter your username and password the next time you visit.
Log outCancel
Does COVID-19 Affect Donor Kidney Outcomes? CME / ABIM MOC / CEA large cohort study suggests that transplantation of kidneys from donors with active or resolved COVID-19 is safe in the medium-term.
Anemia of CKD… Are We Missing the Boat?CME / ABIM MOCDo you know which patients with chronic kidney disease (CKD) should be screened for anemia and how to effectively manage anemia in patients with CKD?
Medscape Education Infectious Diseases, November 2022
Kidney Transplant: Before, During, and After CME / ABIM MOCA discussion on current and emerging immunosuppressive therapy after kidney transplant and their impact on long-term outcomes.
Medscape Education Nephrology, October 2022
Patient Case: To Screen or Not to Screen for Chronic Kidney DiseaseCME / ABIM MOCFind out why urinary albumin-creatinine ratio (uACR) in addition to estimated glomerular filtration rate (eGFR) is the best method to screen for chronic kidney disease (CKD) in your patients with type 2 diabetes (T2D).
Medscape Education Diabetes & Endocrinology, October 2022
Advancing Chronic Kidney Disease Diagnosis in the Modern WorldCME / ABIM MOCHow could the latest recommendations for chronic kidney disease (CKD) screening and estimated glomerular filtration rate (eGFR) reporting impact your practice? Find out in this 15-minute lecture.
Kidney transplantation is the treatment of choice for most patients with end-stage renal disease, and pancreas transplantation is the only treatment for type 1 diabetes mellitus that can induce insulin-independent normoglycemia. The major challenges in this and the next decade are to: make available more organs for transplantation through maximization of the donor pool; design more effective and less toxic immunosuppressive regimens; and extend long-term survival.
